JOURNAL OF VECTOR BORNE DISEASES, published by Wolters Kluwer Medknow Publications, is an esteemed peer-reviewed journal dedicated to advancing the understanding of vector-borne diseases, a significant concern in global health. Established in 2003, this open-access journal has fostered a rich repository of research, spanning clinical studies, epidemiology, and control strategies related to diseases transmitted by vectors like mosquitoes and ticks. With its impact continuing to grow, as evident from its Q3 quartile rankings in Infectious Diseases and Medicine (miscellaneous) categories in 2023, the journal provides a critical platform for researchers and healthcare professionals to disseminate findings that inform policy and practice. With the aim of highlighting contemporary issues and innovations in the field, it is vital for ongoing discussions and advancements in vector-borne disease management. Evaluation metrics from Scopus, although currently positioned in the lower percentiles, underscore the journal's importance as an emerging source of scholarly information in parasitology and immunology. By adhering to its open-access model since 2012, the journal ensures that its valuable content is readily accessible, facilitating widespread knowledge transfer and collaboration among scholars and practitioners alike.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.

Revista da Sociedade Brasileira de Medicina Tropical is a distinguished open-access journal published by the Sociedade Brasileira de Medicina Tropical, focusing on the critical fields of Infectious Diseases, Microbiology, and Parasitology. Since its inception in 1972, this journal has committed to disseminating impactful research that addresses pressing global health challenges, particularly in tropical and infectious diseases prevalent in Brazil and beyond. With a robust publication history, it has been recognized as a Q3 journal in esteemed categories, reflecting its valuable contributions to scientific literature and its ranking in various Scopus categories, including a notable position in Parasitology. Researchers, professionals, and students are encouraged to engage with its rich repository of research, which has been freely accessible since 1997, fostering a wide-reaching impact on public health strategy and scientific innovation.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

Current Research in Parasitology & Vector-Borne Diseases, published by ELSEVIER, is an influential journal dedicated to advancing the understanding of parasitology and vector-borne diseases. With an ISSN of 2667-114X, this journal is highly esteemed in the field, holding a prestigious Q1 quartile ranking in categories such as Animal Science and Zoology, Insect Science, and Parasitology, as well as a notable Q2 ranking in Virology for 2023. The journal's focus spans a crucial intersection of disciplines, offering a platform for innovative research that directly addresses global health challenges posed by parasites and vectors. Researchers benefit from its robust open-access model, which facilitates unrestricted dissemination of knowledge, making essential findings accessible to a wider audience. The journal continues to play a pivotal role in fostering scholarly dialogue and interdisciplinary collaboration within the scientific community, serving as a vital resource for professionals, students, and academicians interested in the dynamic and evolving field of parasitology.

Welcome to Epidemiology and Health, a premier open-access journal dedicated to advancing knowledge in the fields of epidemiology and public health. Published by the Korean Society of Epidemiology since 1979, this journal serves as a vital platform for researchers, professionals, and students alike, promoting innovative research and robust discussion surrounding public health issues. Based in South Korea, it boasts a commendable Q2 ranking in the categories of Epidemiology, Public Health, and Environmental and Occupational Health, reflecting its significant contribution to the scientific community. With its current impact factor ranking it favorably among peers—#124 out of 665 in Public Health and #40 out of 148 in Epidemiology—Epidemiology and Health continues to uphold its mission of disseminating high-quality, peer-reviewed research. The journal's commitment to open access ensures that vital epidemiological insights reach a broad audience, supporting the collective goal of improving global health outcomes. Engage with pioneering studies and emerging trends within these critical fields, as we work towards a healthier future.

ACTA TROPICA is a prestigious academic journal published by Elsevier, dedicated to advancing knowledge in the fields of Infectious Diseases, Insect Science, Parasitology, and Veterinary sciences. With an ISSN of 0001-706X and an E-ISSN of 1873-6254, it has established itself as a vital resource since its inception in 1945. The journal is recognized for its significant impact within the scientific community, boasting a Q2 ranking in Infectious Diseases and Parasitology, and a Q1 ranking in both Insect Science and Veterinary (miscellaneous) categories as of 2023. Specifically, it ranks #19 in Scopus for Parasitology and #129 for Infectious Diseases, underscoring its high visibility and relevance in these vital research arenas. ACTA TROPICA is a non-open access journal, ensuring high-quality peer-reviewed content that complements ongoing research and professional practices among scientists, researchers, and students. Explore groundbreaking studies and contribute to the ongoing dialogue within your field by selecting ACTA TROPICA as your next publication destination.

Tropical Medicine and Health is a prestigious open-access journal published by BMC that serves as a vital platform for researchers and health professionals focusing on the fields of tropical medicine, infectious diseases, and public health. With an ISSN of 1348-8945 and an E-ISSN of 1349-4147, the journal has established itself in the academic community since its inception in 2004, bridging the gap between research and real-world applications in managing tropical diseases. Recognized for its quality, it holds a commendable Q2 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories, positioned in the 2023 Scopus rankings within the 85th and 74th percentiles, respectively. Researchers can access high-quality, peer-reviewed articles that contribute significantly to advancing knowledge in the field. With a commitment to fostering open scientific dialogue, Tropical Medicine and Health is not just a journal, but a collaborative space for researchers, students, and practitioners working to improve health outcomes in tropical regions worldwide.

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.